Summary of Product Characteristics
last updated on the eMC:
17/11/2009
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 17/11/2009 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
-
Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 05-Aug-2009 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
7. Marketing authorisation holder
The address has changed to Orion Corporation, Orionintie 1, FI-02200 Espoo, Finland
8.) Marketing authorisation number
This has changed to PL 27925/0050
10.) date of revision of text
This has changed to 05 August 2009
|
|
Updated on 12/02/2009 and displayed until 17/11/2009
|
Reasons for adding or updating:
|
-
Correction of spelling/typing errors
|
| Date of revision of text on the SPC: 01-Feb-2007 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| None provided |
|
Updated on 23/02/2007 and displayed until 12/02/2009
|
Reasons for adding or updating:
|
|
|
|
